FDA Nanotechnology Task Force Takes a Step Forward

According to Project on Emerging Nanotechnologies Director David Rejeski, “Today, FDA took a step forward in fulfilling its responsibilities for nanotechnology oversight. If nanotechnology regulation was a baseball game, FDA has scored the first run in the first inning. But the agency must act rapidly to adopt and fully implement the Nanotechnology Task Force’s recommendations. Without moving quickly and building on the recommendations in the Task Force report, FDA will not be able to keep pace with today’s rapidly developing nanotechnology market or engender consumer and investor confidence in emerging products.”

View the PDF